Monoclonal antibody A5B7 I-131

Drug Profile

Monoclonal antibody A5B7 I-131

Alternative Names: Anti-CEA monoclonal antibody A5B7-I-131

Latest Information Update: 31 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cancer Research UK
  • Class Antineoplastics; Monoclonal antibodies; Radiopharmaceuticals
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Colorectal cancer

Most Recent Events

  • 08 Nov 2000 A preclinical study has been added to the Cancer pharmacodyanmics section
  • 30 Jul 1996 Phase-I/II clinical trials for Colorectal cancer in United Kingdom (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top